---
title: "EKSO Bionics (EKSO.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/EKSO.US.md"
symbol: "EKSO.US"
name: "EKSO Bionics"
industry: "Health Care Equipment"
datetime: "2026-05-20T06:05:23.470Z"
locales:
  - [en](https://longbridge.com/en/quote/EKSO.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/EKSO.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/EKSO.US.md)
---

# EKSO Bionics (EKSO.US)

## Company Overview

Ekso Bionics Holdings, Inc. designs, develops, distributes, and commercializes exoskeleton products in the Americas, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides EksoNR, a wearable robotic exoskeleton; Ekso Indego Therapy, a powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; and Ekso EVO, a wearable upper body exoskeleton. It also develops Ekso Nomad, a power Knee Ankle Foot Orthosis or KAFO; and MediTouch BalanceTutor rehabilitation system, a multidirectional perturbation treadmill outfitted.

| Item | Detail |
|------|--------|
| Industry | Health Care Equipment |
| Exchange | US Market |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: D
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:16.000Z

**Overall: D (0.74)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 167 / 183 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: D

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -34.08% |  |
| Net Profit YoY | -47.47% |  |
| P/B Ratio | 0.00 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 0.00 |  |
| Revenue | 11565000.00 |  |

#### Multi Score Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -215.33% | E |
| Profit Margin | -135.66% | E |
| Gross Margin | 50.16% | B |
| Revenue YoY | -34.08% | E |
| Net Profit YoY | -47.47% | D |
| Total Assets YoY | -27.98% | E |
| Net Assets YoY | -54.77% | E |
| Cash Flow Margin | 75.14% | C |
| OCF YoY | -34.08% | E |
| Turnover | 0.49 | C |
| Gearing Ratio | 70.82% | D |

```chart-data:radar
{
  "title": "Longbridge Financial Score - EKSO Bionics",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-34.08%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-47.47%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "0.00",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "0.00",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "11565000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "D",
      "indicators": [
        {
          "name": "ROE",
          "value": "-215.33%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "-135.66%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "50.16%",
          "rating": "B"
        },
        {
          "name": "Revenue YoY",
          "value": "-34.08%",
          "rating": "E"
        },
        {
          "name": "Net Profit YoY",
          "value": "-47.47%",
          "rating": "D"
        },
        {
          "name": "Total Assets YoY",
          "value": "-27.98%",
          "rating": "E"
        },
        {
          "name": "Net Assets YoY",
          "value": "-54.77%",
          "rating": "E"
        },
        {
          "name": "Cash Flow Margin",
          "value": "75.14%",
          "rating": "C"
        },
        {
          "name": "OCF YoY",
          "value": "-34.08%",
          "rating": "E"
        },
        {
          "name": "Turnover",
          "value": "0.49",
          "rating": "C"
        },
        {
          "name": "Gearing Ratio",
          "value": "70.82%",
          "rating": "D"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -2.64 | 102/183 | - | - | - |
| PB | 20.10 | 139/183 | 4.00 | 1.48 | 0.74 |
| PS (TTM) | 3.63 | 77/183 | 2.79 | 0.99 | 0.55 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Delcath (DCTH.US) | C | A | B | A | A | A |
| 02 | Electromed (ELMD.US) | A | B | A | A | B | A |
| 03 | Intuitive Surgical (ISRG.US) | A | B | C | A | B | B |
| 04 | Stryker (SYK.US) | A | C | C | C | B | B |
| 05 | Boston Scientific (BSX.US) | A | B | C | C | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2025-12-31T05:00:00.000Z

Total Analysts: **2**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 1 | 50% |
| Hold | 1 | 50% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 11.80 |
| Highest Target | 9.50 |
| Lowest Target | 9.50 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/EKSO.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/EKSO.US/norm.md)
- [Related News](https://longbridge.com/en/quote/EKSO.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/EKSO.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**